Trecondi Uses, Dosage, Side Effects and more
Trecondi is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Trecondi has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
| Attribute | Details |
|---|---|
| Trade Name | Trecondi |
| Generic | Treosulfan |
| Treosulfan Other Names | DIHYDROXYBUSULFAN, OVASTAT, Treosulfan |
| Type | infusion |
| Formula | C6H14O8S2 |
| Weight | Average: 278.29 Monoisotopic: 278.013009759 |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | medac GmbH |
| Available Country | United Kingdom |
| Last Updated: | January 7, 2025 at 1:49 am |
